Literature DB >> 11247763

Angiotensin II stimulates cardiac L-type Ca(2+) current by a Ca(2+)- and protein kinase C-dependent mechanism.

E A Aiello1, H E Cingolani.   

Abstract

Angiotensin II (ANG II) evokes positive inotropic responses in various species. However, the effects of this peptide on L-type Ca(2+) currents (I(Ca)) are still controversial. We report in this study that the effects of ANG II on I(Ca) differ depending on the mode of patch-clamp technique used, standard whole cell (WC) or perforated patch (PP). No significant effects of ANG II (0.5 microM) were observed when WC in cells dialyzed with high EGTA was used. However, when the intracellular milieu was preserved using PP, ANG II induced a significant 77 +/- 6% increase in I(Ca) (-2.2 +/- 0.3 in control and -3.9 +/- 0.6 pA/pF in ANG II, n = 8, P < 0.05). When WC was used in cells dialyzed with low Ca(2+) buffer capacity (EGTA 0.1 mM), ANG II was able to induce an increase in I(Ca) (-3.5 +/- 0.3 in control vs. -4.8 +/- 0.4 pA/pF in ANG II, n = 13, P < 0.05). This increase was prevented when the cells were also dialyzed with the protein kinase C (PKC) inhibitor chelerythrine (50 microM) or calphostin C (1 microM). The above results allow us to conclude that strong intracellular Ca(2+) buffering prevents the physiological actions of ANG II on cardiac I(Ca), which are also dependent on activation of PKC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247763     DOI: 10.1152/ajpheart.2001.280.4.H1528

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  25 in total

1.  Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect.

Authors:  Adelino F Leite-Moreira; Paulo Castro-Chaves; Pedro Pimentel-Nunes; Alexandre Lima-Carneiro; Miguel S Guerra; João Bruno Soares; João Ferreira-Martins
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Antibodies against the cardiac sodium/bicarbonate co-transporter (NBCe1) as pharmacological tools.

Authors:  Verónica C De Giusti; Alejandro Orlowski; María C Villa-Abrille; Gladys E Chiappe de Cingolani; Joseph R Casey; Bernardo V Alvarez; Ernesto A Aiello
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

3.  Cardiac electrophysiology delivered a "grand slam" by angiotensin II: the third explanation of transmural cardiac electrical activity gradients.

Authors:  Donald W Hilgemann
Journal:  Biophys J       Date:  2014-06-03       Impact factor: 4.033

4.  Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling.

Authors:  Zhenghang Zhao; Nadezhda Fefelova; Mayilvahanan Shanmugam; Peter Bishara; Gopal J Babu; Lai-Hua Xie
Journal:  J Mol Cell Cardiol       Date:  2010-11-06       Impact factor: 5.000

5.  Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Authors:  Peiyong Zhai; Mitsutaka Yamamoto; Jonathan Galeotti; Jing Liu; Malthi Masurekar; Jill Thaisz; Keiichi Irie; Eric Holle; Xianzhong Yu; Sabina Kupershmidt; Dan M Roden; Thomas Wagner; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

6.  Angiotensin II activates CaV 1.2 Ca2+ channels through β-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes.

Authors:  Toshihide Kashihara; Tsutomu Nakada; Katsuhiko Kojima; Toshikazu Takeshita; Mitsuhiko Yamada
Journal:  J Physiol       Date:  2017-04-20       Impact factor: 5.182

7.  Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.

Authors:  María V Correa; Mariela B Nolly; Claudia I Caldiz; Gladys E Chiappe de Cingolani; Horacio E Cingolani; Irene L Ennis
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

8.  Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Authors:  Hairuo Wen; Judith K Gwathmey; Lai-Hua Xie
Journal:  World J Hypertens       Date:  2012-08-23

9.  Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor.

Authors:  Y H Wang; C X Shi; F Dong; J W Sheng; Y F Xu
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

10.  Atorvastatin blocks increased l-type Ca2+ current and cell injury elicited by angiotensin II via inhibiting oxide stress.

Authors:  Yanzhuo Ma; Lingfeng Kong; Shuying Qi; Dongmei Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-02       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.